ISMP Releases Targeted Medication Safety Best Practices for Hospitals
An ISMP report highlights drug name confusion as one of the leading causes of medication errors.
An ISMP report highlights drug name confusion as one of the leading causes of medication errors.
Johnson & Johnson has announced it is increasing its opioid crisis settlement commitment to $5 billion.
A class action lawsuit calls on the makers of opioids to pay for the medical care of children born addicted to their drugs.
Johnson & Johnson will pay $20.4 million to settle opioid crisis lawsuits brought by two Ohio counties just three weeks before a trial was set to begin.
Purdue Pharma has reportedly entered into a $12 billion tentative settlement agreement to resolve thousands of opioid crisis lawsuits filed by states and cities, which will drive the company into…
Plaintiffs involved in opioid crisis lawsuits have proposed a settlement negotiation structure which would involve every city and county within the United States.
Oklahoma and Purdue Pharma have reached a $270 million settlement to resolve claims the company's mislead the public about the safety of OxyContin, helping to spur the national opioid crisis.
New documents suggest Purdue Pharma aggressively pushed OxyContin prescriptions despite the risks of addiction, then called for company officials to shift the blame for the opioid crisis onto addicts and…
The U.S. JPML has refused to create a separate multidistrict litigation for lawsuits over children suffering from neonatal abstinence syndrome caused by opioids.
Manufacturers of opioids say they oppose the creation of a separate federal consolidated litigation for cases involving infants born addicted to opioids.